Associated Banc-Corp’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.1M | Buy |
480,358
+106,526
| +28% | +$8.52M | 0.8% | 32 |
|
|
2025
Q4 | $35.6M | Buy |
373,832
+1,389
| +0.4% | +$136K | 0.91% | 26 |
|
|
2025
Q3 | $36.4M | Buy |
372,443
+383
| +0.1% | +$39.7K | 0.96% | 27 |
|
|
2025
Q2 | $40M | Sell |
372,060
-2,821
| -0.8% | -$285K | 1.13% | 22 |
|
|
2025
Q1 | $37.8M | Sell |
374,881
-48,370
| -11% | -$4.87M | 1.15% | 23 |
|
|
2024
Q4 | $37.8M | Buy |
423,251
+537
| +0.1% | +$47.3K | 1.14% | 20 |
|
|
2024
Q3 | $35.4M | Sell |
422,714
-1,539
| -0.4% | -$121K | 1.04% | 25 |
|
|
2024
Q2 | $32.7M | Sell |
424,253
-12,860
| -3% | -$941K | 1.02% | 25 |
|
|
2024
Q1 | $29.9M | Buy |
437,113
+8,116
| +2% | +$522K | 0.95% | 28 |
|
|
2023
Q4 | $24.8M | Sell |
428,997
-1,191
| -0.3% | -$63.6K | 0.86% | 37 |
|
|
2023
Q3 | $22.7M | Buy |
430,188
+4,497
| +1% | +$236K | 0.88% | 33 |
|
|
2023
Q2 | $23M | Sell |
425,691
-19,025
| -4% | -$994K | 0.87% | 33 |
|
|
2023
Q1 | $22.2M | Buy |
444,716
+3,584
| +0.8% | +$169K | 0.89% | 33 |
|
|
2022
Q4 | $20.4M | Buy |
441,132
+16,845
| +4% | +$729K | 0.85% | 35 |
|
|
2022
Q3 | $16.4M | Buy |
424,287
+5,468
| +1% | +$219K | 0.76% | 41 |
|
|
2022
Q2 | $15.6M | Buy |
418,819
+692
| +0.2% | +$28.2K | 0.68% | 48 |
|
|
2022
Q1 | $18.5M | Sell |
418,127
-6,830
| -2% | -$296K | 0.71% | 46 |
|
|
2021
Q4 | $18.1M | Sell |
424,957
-5,287
| -1% | -$222K | 0.66% | 50 |
|
|
2021
Q3 | $18.7M | Buy |
430,244
+7,555
| +2% | +$334K | 0.74% | 41 |
|
|
2021
Q2 | $18.1M | Sell |
422,689
-110,389
| -21% | -$4.64M | 0.72% | 42 |
|
|
2021
Q1 | $17.4M | Buy |
533,078
+10,840
| +2% | +$410K | 1.08% | 28 |
|
|
2020
Q4 | $18.8M | Sell |
522,238
-12,572
| -2% | -$453K | 0.73% | 41 |
|
|
2020
Q3 | $20.4M | Sell |
534,810
-18,933
| -3% | -$730K | 0.88% | 36 |
|
|
2020
Q2 | $19.4M | Buy |
553,743
+20,665
| +4% | +$744K | 0.88% | 38 |
|
|
2020
Q1 | $17.4M | Buy |
533,078
+40,178
| +8% | +$1.57M | 0.93% | 35 |
|
|
2019
Q4 | $22.3M | Buy |
492,900
+6,524
| +1% | +$273K | 1.11% | 29 |
|
|
2019
Q3 | $19.8M | Buy |
486,376
+12,422
| +3% | +$526K | 1.06% | 29 |
|
|
2019
Q2 | $20.4M | Buy |
473,954
+33,202
| +8% | +$1.28M | 1.12% | 27 |
|
|
2019
Q1 | $16.9M | Buy |
440,752
+22,107
| +5% | +$844K | 0.98% | 31 |
|
|
2018
Q4 | $14.8M | Sell |
418,645
-1,935
| -0.5% | -$70.2K | 0.96% | 29 |
|
|
2018
Q3 | $16.2M | Buy |
420,580
+12,075
| +3% | +$422K | 0.9% | 33 |
|
|
2018
Q2 | $13.4M | Sell |
408,505
-11,548
| -3% | -$348K | 0.78% | 40 |
|
|
2018
Q1 | $11.5M | Buy |
420,053
+80,673
| +24% | +$2.19M | 0.65% | 50 |
|
|
2017
Q4 | $8.41M | Buy |
339,380
+35,163
| +12% | +$970K | 0.45% | 61 |
|
|
2017
Q3 | $8.87M | Buy |
+304,217
| New | +$8.4M | 0.49% | 63 |
|
Other funds holding BSX
VCM
VPM
Associated Banc-Corp's BSX Position: Q1 2026 in Review
Associated Banc-Corp increased its Boston Scientific (BSX) stake by 28% in Q1 2026, buying an estimated $8.52M and bringing the position to 480,358 shares worth $30.1M. The position accounts for 0.8% of the portfolio, ranked #32.
Associated Banc-Corp first reported a position in BSX in Q3 2017 and has held it in 35 quarters since. The position peaked at $40M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Associated Banc-Corp held 480,358 shares of Boston Scientific worth $30.1M as of Q1 2026.
- Associated Banc-Corp bought 106,526 Boston Scientific shares in Q1 2026, an estimated $8.52M.
- Boston Scientific made up 0.8% of Associated Banc-Corp's portfolio in Q1 2026, its #32 holding.
- Associated Banc-Corp first reported a position in Boston Scientific in Q3 2017 and has held it in 35 quarters since.
- Associated Banc-Corp's Boston Scientific position peaked at $40M in Q2 2025.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.